$ANCN Announces Shareholder Approval of the Merger with Chemomab

Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing

Anchiano shareholders approve all resolutions at shareholder meeting

The merged company is expected to receive approximate gross proceeds from the private financing of $45.5 million, which will be used to advance the Chemomab pipeline.

finance.yahoo.com/news/anchiano-announces-shareholder-approval-merger-215400351.html